Having trouble accessing articles? Reset your cache.

InSite, Bausch + Lomb, Bess Royalty, SWK Holdings deal

InSite sold its royalty on sales of Besivance besifloxacin ophthalmic solution to Bess Royalty and the SWK Funding

Read the full 187 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE